ImmunityBio Analyst Price Targets

ImmunityBio Inc

IBRXNASDAQ

Trade with Public

$8.33

-0.09-1.07%

Ult. Agg.: Oct 20, 9:19 AM

$8.33

-0.09-1.07%

Panoramica Notizie Previsioni utili EventiObiettivi di prezzoDati finanziari Sentiment Azionariato Confronta Opzioni Rapporto azionario

ImmunityBio Analyst Price Targets

Wall Street analyst price targets and consensus rating for ImmunityBio (IBRX).

Price Target Range — 11 Quarters

Analyst Consensus — 6 Analysts

6Buy

Consensus RatingBuy# Analysts6Avg. Consensus PT$15Upside to Avg. PT+83.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 15, 2026	Jefferies	Kelly Shi	PT Raise	Buy	$12→$14
Oct 15, 2026	HC Wainwright & Co.	Andres Y. Maldonado	Maintained	Buy	$15
Jun 2, 2026	HC Wainwright & Co.	Andres Y. Maldonado	Maintained	Buy	$15
May 21, 2026	BTIG	Jeet Mukherjee	Maintained	Buy	$12
May 20, 2026	HC Wainwright & Co.	Andres Y. Maldonado	Maintained	Buy	$15
May 5, 2026	D. Boral Capital	Jason Kolbert	Maintained	Buy	$23
Apr 21, 2026	D. Boral Capital	Jason Kolbert	Maintained	Buy	$23
Apr 8, 2026	D. Boral Capital	Jason Kolbert	Maintained	Buy	$23
Mar 26, 2026	D. Boral Capital	Jason Kolbert	Maintained	Buy	$23
Mar 23, 2026	D. Boral Capital	Jason Kolbert	Maintained	Buy	$23
Mar 17, 2026	D. Boral Capital	Jason Kolbert	Maintained	Buy	$23
Mar 12, 2026	BTIG	Jeet Mukherjee	Assumes	Buy	$13
Mar 9, 2026	D. Boral Capital	Jason Kolbert	Maintained	Buy	$23
Mar 4, 2026	Piper Sandler	Edward Tenthoff	PT Raise	Overweight	$7→$12
Feb 23, 2026	HC Wainwright & Co.	Andres Y. Maldonado	PT Raise	Buy	$10→$15
Feb 23, 2026	D. Boral Capital	Jason Kolbert	Maintained	Buy	$23
Feb 19, 2026	D. Boral Capital	Jason Kolbert	Maintained	Buy	$24
Feb 17, 2026	D. Boral Capital	Jason Kolbert	Maintained	Buy	$24
Jan 26, 2026	HC Wainwright & Co.	Andres Y. Maldonado	PT Raise	Buy	$8→$10
Jan 23, 2026	D. Boral Capital	Jason Kolbert	Maintained	Buy	$24

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Jefferies Maintains Buy on ImmunityBio, Raises Price Target to $14

Jefferies analyst Kelly Shi maintains ImmunityBio (NASDAQ:IBRX) with a Buy and raises the price target from $12 to $14.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on ImmunityBio, Maintains $15 Price Target

HC Wainwright & Co. analyst Andres Y. Maldonado reiterates ImmunityBio (NASDAQ:IBRX) with a Buy and maintains $15 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on ImmunityBio, Maintains $15 Price Target

HC Wainwright & Co. analyst Andres Y. Maldonado reiterates ImmunityBio (NASDAQ:IBRX) with a Buy and maintains $15 price target.

Benzinga Newsdesk

PRO
BTIG Reiterates Buy on ImmunityBio, Maintains $12 Price Target

BTIG analyst Jeet Mukherjee reiterates ImmunityBio (NASDAQ:IBRX) with a Buy and maintains $12 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on ImmunityBio, Maintains $15 Price Target

HC Wainwright & Co. analyst Andres Y. Maldonado reiterates ImmunityBio (NASDAQ:IBRX) with a Buy and maintains $15 price target.

Benzinga Newsdesk

PRO
BTIG Assumes ImmunityBio at Buy, Announces Price Target of $13

BTIG analyst Jeet Mukherjee assumes ImmunityBio (NASDAQ:IBRX) with a Buy rating and announces Price Target of $13.

Benzinga Newsdesk

ImmunityBio Inc

ImmunityBio Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Jefferies Maintains Buy on ImmunityBio, Raises Price Target to $14

PRO
HC Wainwright & Co. Reiterates Buy on ImmunityBio, Maintains $15 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on ImmunityBio, Maintains $15 Price Target

PRO
BTIG Reiterates Buy on ImmunityBio, Maintains $12 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on ImmunityBio, Maintains $15 Price Target

PRO
BTIG Assumes ImmunityBio at Buy, Announces Price Target of $13

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

ImmunityBio Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Jefferies Maintains Buy on ImmunityBio, Raises Price Target to $14

PRO
HC Wainwright & Co. Reiterates Buy on ImmunityBio, Maintains $15 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on ImmunityBio, Maintains $15 Price Target

PRO
BTIG Reiterates Buy on ImmunityBio, Maintains $12 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on ImmunityBio, Maintains $15 Price Target

PRO
BTIG Assumes ImmunityBio at Buy, Announces Price Target of $13

People Also Watch

People Also Watch

ImmunityBio Inc

ImmunityBio Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROJefferies Maintains Buy on ImmunityBio, Raises Price Target to $14

PROHC Wainwright & Co. Reiterates Buy on ImmunityBio, Maintains $15 Price Target

PROHC Wainwright & Co. Reiterates Buy on ImmunityBio, Maintains $15 Price Target

PROBTIG Reiterates Buy on ImmunityBio, Maintains $12 Price Target

PROHC Wainwright & Co. Reiterates Buy on ImmunityBio, Maintains $15 Price Target

PROBTIG Assumes ImmunityBio at Buy, Announces Price Target of $13

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

ImmunityBio Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROJefferies Maintains Buy on ImmunityBio, Raises Price Target to $14

PROHC Wainwright & Co. Reiterates Buy on ImmunityBio, Maintains $15 Price Target

PROHC Wainwright & Co. Reiterates Buy on ImmunityBio, Maintains $15 Price Target

PROBTIG Reiterates Buy on ImmunityBio, Maintains $12 Price Target

PROHC Wainwright & Co. Reiterates Buy on ImmunityBio, Maintains $15 Price Target

PROBTIG Assumes ImmunityBio at Buy, Announces Price Target of $13

People Also Watch

People Also Watch

PRO
Jefferies Maintains Buy on ImmunityBio, Raises Price Target to $14

PRO
HC Wainwright & Co. Reiterates Buy on ImmunityBio, Maintains $15 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on ImmunityBio, Maintains $15 Price Target

PRO
BTIG Reiterates Buy on ImmunityBio, Maintains $12 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on ImmunityBio, Maintains $15 Price Target

PRO
BTIG Assumes ImmunityBio at Buy, Announces Price Target of $13

PRO
Jefferies Maintains Buy on ImmunityBio, Raises Price Target to $14

PRO
HC Wainwright & Co. Reiterates Buy on ImmunityBio, Maintains $15 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on ImmunityBio, Maintains $15 Price Target

PRO
BTIG Reiterates Buy on ImmunityBio, Maintains $12 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on ImmunityBio, Maintains $15 Price Target

PRO
BTIG Assumes ImmunityBio at Buy, Announces Price Target of $13